Cesar Augusto Pinheiro Ferreira Alves

Cesar Augusto Pinheiro Ferreira Alves

Auto-generated profile, based on publicly available information

Cesar Augusto Pinheiro Ferreira Alves

Department of Radiology, Boston Children's Hospital, MA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2020 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
CACesar Augusto Pinheiro Ferreira Alves
Cesar Augusto Pinheiro Ferreira Alves
STSara Reis Teixeira
Sara Reis Teixeira
JMJuan Sebastian Martin‐Saavedra
Juan Sebastian Martin‐Saavedra
FGFabrício Guimarães Gonçalves
Fabrício Guimarães Gonçalves
FRFrancesco Lo Russo
Francesco Lo Russo
GZGiulio Zuccoli
Giulio Zuccoli

30 September 2020 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
LGLaiz Laura de Godoy
Laiz Laura de Godoy
CACesar Augusto Pinheiro Ferreira Alves
Cesar Augusto Pinheiro Ferreira Alves
JSJuan Sebastian Martin Saavedra
Juan Sebastian Martin Saavedra
ASAdalberto Studart-Neto
Adalberto Studart-Neto
RNRicardo Nitrini
Ricardo Nitrini
SBSotirios Bisdas
Sotirios Bisdas

1 April 2021 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
SRS.D. Roosendaal
S.D. Roosendaal
TBT. van de Brug
T. van de Brug
CAC.A.P.F. Alves
C.A.P.F. Alves
SBS. Blaser
S. Blaser
AVA. Vanderver
A. Vanderver
MKM.S. van der Knaap
M.S. van der Knaap
BACKGROUND AND PURPOSE: Achieving a specific diagnosis in leukodystrophies is often difficult due to clinical and genetic heterogeneity. Mitochondrial defects cause 5%–10% of leukodystrophies. Our objective was to define MR imaging features commonly shared by mitochondrial leukodystrophies and to distinguish MR imaging patterns related to specific genetic defects. MATERIALS AND METHODS: One hundred thirty-two patients with a mitochondrial leukodystrophy with known genetic defects were identified in the data base of the Amsterdam Leukodystrophy Center. Numerous anatomic structures were systematically assessed on brain MR imaging. Additionally, lesion characteristics were scored. Statistical group analysis was performed for 57 MR imaging features by hierarchic testing on clustered genetic subgroups. RESULTS: MR imaging features indicative of mitochondrial disease that were frequently found included white matter rarefaction (n = 50 patients), well-delineated cysts (n = 20 patients), T2 hyperintensity of the middle blade of the corpus callosum (n = 85 patients), and symmetric abnormalities in deep gray matter structures (n = 42 patients). Several disorders or clusters of disorders had characteristic features. The combination of T2 hyperintensity in the brain stem, middle cerebellar peduncles, and thalami was associated with complex 2 deficiency. Predominantly periventricular localization of T2 hyperintensities and cystic lesions with a distinct border was associated with defects in complexes 3 and 4. T2-hyperintense signal of the cerebellar cortex was specifically associated with variants in the gene NUBPL. T2 hyperintensities predominantly affecting the directly subcortical cerebral white matter, globus pallidus, and substantia nigra were associated with Kearns-Sayre syndrome. CONCLUSIONS: In a large group of patients with a mitochondrial leukodystrophy, general MR imaging features suggestive of mitochondrial disease were found. Additionally, we identified several MR imaging patterns correlating with specific genotypes. Recognition of these patterns facilitates the diagnosis in future patients.

22 September 2022 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
MWMatthew T. Whitehead
Matthew T. Whitehead
MBMatthew J Barkovich
Matthew J Barkovich
JSJ. Sidpra
J. Sidpra
CAC.A. Alves
C.A. Alves
DMD.M. Mirsky
D.M. Mirsky
KMKshitij Mankad
Kshitij Mankad
BACKGROUND AND PURPOSE: The traditionally described Dandy-Walker malformation comprises a range of cerebellar and posterior fossa abnormalities with variable clinical severity. We aimed to establish updated imaging criteria for Dandy-Walker malformation on the basis of cerebellar development. MATERIALS AND METHODS: In this multicenter study, retrospective MR imaging examinations from fetuses and children previously diagnosed with Dandy-Walker malformation or vermian hypoplasia were re-evaluated, using the choroid plexus/tela choroidea location and the fastigial recess shape to differentiate Dandy-Walker malformation from vermian hypoplasia. Multiple additional measures of the posterior fossa and cerebellum were also obtained and compared between Dandy-Walker malformation and other diagnoses. RESULTS: Four hundred forty-six examinations were analyzed (174 fetal and 272 postnatal). The most common diagnoses were Dandy-Walker malformation (78%), vermian hypoplasia (14%), vermian hypoplasia with Blake pouch cyst (9%), and Blake pouch cyst (4%). Most measures were significant differentiators of Dandy-Walker malformation from non-Dandy-Walker malformation both pre- and postnatally (P < .01); the tegmentovermian and fastigial recess angles were the most significant quantitative measures. Posterior fossa perimeter and vascular injury evidence were not significant differentiators pre- or postnatally (P > .3). The superior posterior fossa angle, torcular location, and vermian height differentiated groups postnatally (P < .01), but not prenatally (P > .07). CONCLUSIONS: As confirmed by objective measures, the modern Dandy-Walker malformation phenotype is best defined by inferior predominant vermian hypoplasia, an enlarged tegmentovermian angle, inferolateral displacement of the tela choroidea/choroid plexus, an obtuse fastigial recess, and an unpaired caudal lobule. Posterior fossa size and torcular location should be eliminated from the diagnostic criteria. This refined phenotype may help guide future study of the numerous etiologies and varied clinical outcomes.

1 November 2020 in RadioGraphics
Verified
Journal Article
Closed access
FGFabrício Goncalves
Fabrício Goncalves
CACésar Augusto Pinheiro Ferreira Alves
César Augusto Pinheiro Ferreira Alves
BHBeth Heuer
Beth Heuer
JPJames Peterson
James Peterson
AVAngela N. Viaene
Angela N. Viaene
AVArastoo Vossough
Arastoo Vossough
Knowledge of the diagnostic imaging clues, clinical and imaging findings, and main differential diagnoses of primary mitochondrial disorders of the pediatric central nervous system is useful in rea... Primary mitochondrial disorders (PMDs) constitute the most common cause of inborn errors of metabolism in children, and they frequently affect the central nervous system. Neuroimaging findings of P...

6 April 2023 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
CAC.A.P.F. Alves
C.A.P.F. Alves
AZA. Zandifar
A. Zandifar
JPJ.T. Peterson
J.T. Peterson
STS.Z. Tara
S.Z. Tara
RGRebecca Ganetzky
Rebecca Ganetzky
AGA.C. Goldstein
A.C. Goldstein
BACKGROUND AND PURPOSE: An increased number of pathogenic variants have been described in mitochondrial encephalomyopathy lactic acidosis and strokelike episodes (MELAS). Different imaging presentations have emerged in parallel with a growing recognition of clinical and outcome variability, which pose a diagnostic challenge to neurologists and radiologists and may impact an individual patient’s response to therapeutic interventions. By evaluating clinical, neuroimaging, laboratory, and genetic findings, we sought to improve our understanding of the sources of potential phenotype variability in patients with MELAS. MATERIALS AND METHODS: This retrospective single-center study included individuals who had confirmed mitochondrial DNA pathogenic variants and a diagnosis of MELAS and whose data were reviewed from January 2000 through November 2021. The approach included a review of clinical, neuroimaging, laboratory, and genetic data, followed by an unsupervised hierarchical cluster analysis looking for sources of phenotype variability in MELAS. Subsequently, experts identified “victory-variables” that best differentiated MELAS cohort clusters. RESULTS: Thirty-five patients with a diagnosis of mitochondrial DNA–based MELAS (median age, 12 years; interquartile range, 7–24 years; 24 female) were eligible for this study. Fifty-three discrete variables were evaluated by an unsupervised cluster analysis, which revealed that two distinct phenotypes exist among patients with MELAS. After experts reviewed the variables, they selected 8 victory-variables with the greatest impact in determining the MELAS subgroups: developmental delay, sensorineural hearing loss, vision loss in the first strokelike episode, Leigh syndrome overlap, age at the first strokelike episode, cortical lesion size, regional brain distribution of lesions, and genetic groups. Ultimately, 2-step differentiating criteria were defined to classify atypical MELAS. CONCLUSIONS: We identified 2 distinct patterns of MELAS: classic MELAS and atypical MELAS. Recognizing different patterns in MELAS presentations will enable clinical and research care teams to better understand the natural history and prognosis of MELAS and identify the best candidates for specific therapeutic interventions.